| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.31 | 0.04 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.25 | 3e-07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.2 | 7e-05 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |